QBE share price riding on these 3 'macro tailwinds', analysts say

Analysts are constructive on QBE.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • QBE looks well-positioned to benefit from a number of macroeconomic tailwinds
  • Interest rates, higher premiums on crops and commodity insurance, and potential improved climate-risk metrics are all factors
  • In the past 12 months, the QBE share price has climbed 26%

Shares in QBE Insurance Group Ltd (ASX: QBE) are trading at $12.26 apiece, up 1.49% on Thursday.

After some fairly widely-dispersed pricing, QBE stock has managed to thrust itself off a low of $10.08 in March and race higher to its current levels.

Analysts are constructive on the company and reckon it's well-positioned to benefit from a slew of macro catalysts. Let's take a look.

TradingView Chart
A team of people giving the thumbs up sign.

Image source: Getty Images

QBE share price to benefit from macro tailwinds

Analysts at UBS have chimed in on the investment debate for QBE in a recent note to clients. They note the insurer is benefitting from a number of industry-specific and macroeconomic tailwinds, making it the preferred insurance share for UBS.

Writing to clients, UBS analyst Scott Russell said factors such as stronger crop pricing are feeding additional income to QBE via gross written premiums from crop insurance customers.

Not only that, but rising bond yields have the potential to send QBE shares higher, he says.

Meanwhile, analysts at JP Morgan have tied QBE's outlook to recent events in the bond markets and a strengthening phase in the insurance cycle.

"As a global commercial insurer, QBE is subject to the vagaries of the insurance cycle and volatile natural catastrophes," the broker wrote.

"Trends in the cycle are currently improving, and there could be further upside from premium rates, providing a tailwind for earnings growth, with investment yields a headwind."

UBS and JP Morgan each rate QBE as a buy. They value QBE at a price of $15 and $15.50 per share respectively.

Meanwhile, Bloomberg Intelligence analyst Matt Ingram reckons market sentiment has improved for QBE based on its improved climate-risk outlook and its 'brilliant basics' program.

He says this could reflect "consensus fiscal 2023 profit that's more than double mean earnings for the last decade".

"The higher earnings reflect underwriting and efficiency improvements thanks to the firm's "brilliant basics" program and better risk selection in the U.S. and European businesses," he wrote earlier this month.

"The 1.3x price/book ratio represents a 25% discount to IAG, the tightest it has been since 2011, reflecting IAG's climate-related costs and QBE's optimism. It remains more expensive than Suncorp despite the latter's superior profitability," he added.

What's the consensus on QBE?

QBE has a consensus valuation of $14.41 per share, according to Bloomberg data. About 91% of analysts covering it rate it a buy right now.

In the past 12 months, the QBE share price has climbed 26%. It is also 9% higher this past month.

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended Insurance Australia Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans rates these ASX shares as buys with up to 55% upside

The broker has good things to say about these shares.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Buy, hold, sell: Woodside, Rio Tinto, NAB shares

We review three fresh buy, hold, and sell calls from expert market analysts. 

Read more »

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

An oil worker in front of a pumpjack using a tablet.
Broker Notes

Why Woodside shares just got a big buy call

A leading analyst forecasts more outperformance from Woodside’s surging shares.

Read more »